Antitumor agent-130

Overview

Antitumor agent-130 (Compound 7b) is a p300 histone acetyltransferases ( HAT ) inhibitor with an IC 50 of 1.51 μM. Antitumor agent-130 combinates with doxorubicin ( HY-15142A ) can significantly inhibit tumor growth and invasion in vitro and in vivo.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Histone Acetyltransferase

Product Information

• Catalog No.: HY-162128
• CAS No.: 3048422-07-4
• Molecular Formula: C20H18ClNO5
• Molecular Weight: 387.81
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source